About Tesamorelin
Tesamorelin is an FDA-approved synthetic GHRH analog indicated for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. It stimulates physiological growth hormone secretion and has demonstrated significant visceral adipose tissue reduction in clinical trials.
Tesamorelin & Visceral Fat Reduction
Tesamorelin is FDA-approved (as Egrifta) for the reduction of excess abdominal fat. Phase III trials demonstrated significant reduction in visceral adipose tissue with improvements in lipid profiles.
Content sourced from existing TruthTides clinical reference documentation. This is informational only. Consult a qualified physician.
Find a Tesamorelin prescriber in Los Angeles
Browse qualified physicians who prescribe Tesamorelin in the Los Angeles area, or search nationwide via telehealth.
Ask TruthSource AI
Ask anything about Tesamorelin for Visceral Fat Reduction
Get a guardrailed, evidence-anchored answer from our clinical reference tool.
Open Reference ToolFind a Doctor
Search verified Tesamorelin prescribers nationwide
Filter by peptide, location, and telehealth availability.
Open Physician FinderAlso in Los Angeles
Tesamorelin for Visceral Fat Reduction in Other Cities
This content is sourced from existing TruthTides clinical reference documentation. It does not constitute medical advice or treatment recommendations. Consult a qualified physician before starting any peptide therapy.